On-body Drug Delivery Devices White Spaces Analysis

On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key Applicant Profiles

  • Lowest Price Guaranteed From USD 1,299

  • Companies Covered
    503

  • Pages
    180

  • View Count
    12902

On-body Drug Delivery Devices Overview

Chronic diseases, such as diabetes, arthritis, hypertension and cancer, are considered among the leading causes of death, worldwide. In fact, a recent study revealed that the global failure to control the steady rise in preventable risk factors associated with the aforementioned conditions, rendered populations vulnerable to COVID-19. Although there are several national and global-level initiatives focused on educating the masses on prevention and promote healthy living, individuals living with a chronic medical condition are required to medicate on a frequent basis – which is often multiple times in a single day. Lack of adherence to prescribed medication regimens (due to various reasons) and high cost of treatment (a significant share of which stems from non-compliance to treatment), are the major contributing factors to the associated burden on patients and the healthcare system. However, modern therapy administration technology, such as wearable and implantable drug delivery solutions, allows patients to effectively deal with several of the areas of concern related to therapy adherence and treatment costs. 

Historical Trend of IP-related Publications in on body drug delivery devices from the research report of Roots Analysis Analysis of Simple Patent Families of on body drug delivery devices, prepared by Roots Analysis Popular / Relevant Prior Art Search Expressions of on body drug delivery devices, from Roots Analysis report

With provisions to adhere to, or be implanted in the body, this advanced category of drug delivery  solutions are known to (1) enable patients to self-medicate (thereby, saving on routine hospital visit fees), (2) effectively reduce the number of needle-pricks in case of patients who are required to medicate multiple times in a day, (3) administer large volumes (more than 2 mL) of therapeutic formulations over an extended period of time, and (4) improve compliance to therapeutic regimens (some devices include provisions for monitoring / tracking dosing). The advantages of on-body drug delivery devices are numerous; consequently, the demand for such devices is also high and growing, which is projected to grow to a USD 600 million market by 2030. Within such a lucrative and rapidly evolving market it is imperative for innovators and other stakeholders (including interested investors) to regularly track the growing intellectual capital. In this context, we have analyzed the intellectual property landscape related to on-body (wearable and implantable) drug delivery solutions, and developed independent opinions on both historical and recent trends, and other key attributes of the innovation in this upcoming field of medical technology.

Scope of the Report

The “On-body Drug Delivery Devices - Intellectual Property Landscape” report features an extensive study of the historical and current collection of granted patents, patent applications and affiliated documents associated with modern wearable / implantable therapy administration solutions. The information in this report has been presented across two deliverables, namely an Excel sheet, featuring an interactive dashboard, and a PowerPoint presentation, summarizing the ongoing activity in this domain, and key insights drawn from the available data.

This image provides information on Patent Valuation Analysis of on body drug delivery devices This image highlights the high value documents related to on body drug delivery devices This infographic informs about pockets of innovation in on body drug delivery devices, as identified in Roots Analysis report

The report features the following details:

  • Overall Intellectual Property Landscape

An in-depth analysis of the various patents and affiliated IP documents that have been published related to technologies and methods associated with wearable / implantable drug delivery devices, featuring key insights from historical and recent trends

  • Popular / Relevant Prior Art Search Expressions

An examination of IP literature, identifying key words and phrases that are used to describe innovations in portable, large volume drug dispensing solutions, including information on historical usage in IP filings, key affiliated terms (which can be used to further identify similar innovations), and other related trends

  • Patent Valuation Analysis

A competitive benchmarking and valuation analysis, taking into account important IP associated parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (taking into consideration regional GDP), where the IP application was filed

  • Pockets of Innovation and White Spaces

An analysis of the CPC symbols and affiliated families, to identify historical and existing pockets of innovation, featuring an insightful discussion on the prevalent white spaces in this area of research

This image presents key CPC symbols in on body drug delivery devices, as identified in Roots Analysis report This image presents white spaces in on body drug delivery devices, as identified in Roots Analysis report This image highlights the profile of companies engaged in development of on body drug delivery devices
  • Company Profiles

Detailed profiles of the key players that have the maximum number of IP publication in the period between 2001-2021, including overview of the company, financial information (if available), and its proprietary IP related trends

Deiverable Outlines

Excel Deliverable

  1. The first section of the spreadsheet features details on how the input data for this project was collated, including the search strings used to query the lens.org patent database and noise removal criteria.
  2. The second section of the deliverable is a summary MS Excel dashboard, offering a detailed graphical perspective of the intellectual property landscape of on-body drug delivery solutions, highlighting trends key patent / patent application publication trends, CPC symbol usage over time and intellectual capital-related publication trends of key applicants that are engaged in this industry 
  3. The third section of the spreadsheet is an elaborate table, which features a long list of all the intellectual capital (namely granted patents, patent applications, limited patents, amended patents, abstracts, statutory invention registration and search reports) related publications, for which the relevant details are available in the public domain. 
  4. The next section of the deliverable includes an analysis of the key CPC symbols, highlighting usage trends (since 2001) related to the top CPC symbol and CPC families, used by innovators in this field of medical technology to describe their respective products / technologies / methods of use.
  5. The final section of the deliverable includes an analysis of the key applicants that have published the various types of intellectual property documents that have been considered in this report. It also features another table, which includes information on the top 25 applicants, based on the number of intellectual capital related publications, in the period 2001-2021 

PowerPoint Deliverable

  1. The first part of this deliverable features an executive summary of the key insights generated from analyzing the intellectual property landscape associated with on-body drug delivery devices.
  2. The next part provides important details related to on-body drug delivery devices, including key product related definitions, advantages of the technology and the     methodology used (in this project) to query the public database, lens.org, for information on the published intellectual capital related to this innovation.
  3. The third section of the deliverable includes charts and figures describing the overall intellectual property landscape of on-body drug delivery devices and affiliated technologies / methods of use.
  4. The next section of the deliverable includes charts and figures describing the intellectual property landscape of on-body drug delivery devices and affiliated     technologies / methods of use, since 2001.
  5. The subsequent section features insights from a detailed analysis of the titles of patent / patent applications related to wearable and implantable drug delivery solutions.It includes multiple word clouds, which help identify the most important keywords that can be used for prior art research specific to this field.
  6. The sixth section provides our independent views on the relative valuation of the intellectual property related to on-body drug delivery devices, taking into account important associated parameters, such as type of document, year of application, time to expiry, number of citations and jurisdiction (taking into consideration regional GDP), where the IP application was filed.
  7. The next section features an analysis of the CPC symbols and affiliated families, to identify historical and existing pockets of innovation, and also includes an insightful discussion on the prevalent white spaces in this area of research.
  8. Finally, it includes profiles of the companies having the maximum number of intellectual capital related publication in the period between 2001-2021, including overview of the company, financial information (if available), and its proprietary intellectual property publication related trends.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com